This is the standing evidence sheet for Tonix Pharmaceuticals Holding (TNXP): the yardsticks BullScope computes from official SEC filings and market prices. It refreshes whenever a new edition of our research is published, and it is impersonal by design, every reader sees the same page. Nothing here is investment advice; it is the evidence, organized.
The price tag: what buyers pay per dollar of profit
Tonix Pharmaceuticals Holding is priced at 6.8× its annual sales (typical for this company over its past decade: 36.3×).
The tape: what the stock itself has done
- Last price: $4.49 (end-of-day market data as of the edition date · methodology) · 77% below its 52-week high
- Past 6 months: -68.2% · past 12 months: -74.2%
- Day-to-day temperament: jumpy (annualized volatility 71%)
The filed record: straight from the annual reports
| Fiscal year | Revenue | Growth | Operating margin | EPS |
|---|---|---|---|---|
| FY2023 | $0.0B | , | -1523.9% | $-6.85 |
| FY2024 | $0.0B | +29.9% | -1354.3% | $-176.6 |
| FY2025 | $0.0B | +29.8% | -959.1% | $-14.57 |
The road ahead: filed results vs published expectations
| FY2023A | FY2024A | FY2025A | FY2026E | FY2027E | |
|---|---|---|---|---|---|
| Net sales ($M) | 0.0 | 0.0 | 1.4 | 52 to 72 | 45 to 98 |
| Net sales growth (%) | N/M | N/M | N/M | 164 to 240 | -0 |
| Operating margin (%) | -∞ | -∞ | -959 | -250 to -180 | -185 to -70 |
| Diluted EPS ($) | -6.85 | -176.60 | -14.57 | -18.00 to -9.00 | -17.00 to -5.50 |
Columns marked A are actual filed results; E columns are the published consensus ranges the current price is being weighed against.
The four gauges: from the latest edition
Read the full report on Tonix Pharmaceuticals Holding in the BullScope Terminal → It opens with this company loaded.
Edition date: 2026-11-10. This page updates when a new edition is published. Sources: SEC EDGAR filings, Nasdaq prices; computed by BullScope’s published methodology.









